BVT is pleased to announce it will be holding a web enabled conference call on Thursday June 22nd 11am EST. CEO Ashish Malik will provide a corporate update and outline the Company’s progress towards commercialization of BVT’s technology.
BVT is pleased to announce the completion of trials on strawberries and indoor tomatoes in Spain, Italy, and Greece. The trials were conducted using the BVT System consisting of a bumble bee hive with proprietary dispenser technology through which BVT’s proprietary plant beneficial microbe BVT-CR7 is delivered to crops using bumble bees.
BVT is pleased to announce successful, verified results from large commercial scale demonstrations of its proprietary crop production system, with strawberry growers in Florida. The demonstrations were conducted in the Plant City area of Hillsborough County, Florida, the main winter strawberry growing region in the US which produces around 20 million flats of strawberries on 11,000 acres every year.
BVT is continuing to successfully execute on its documented growth strategy while driving towards commercialization of its proprietary system. BVT continues to selectively expand its market opportunities while continuing towards securing US Environmental Protection Agency (EPA) regulatory approval of its BVT-CR7 beneficial microbe.
Bee Vectoring Technologies International Inc. is pleased to announce the closing of the second tranche of its non-brokered private placement for aggregate gross proceeds of $1,428,500 (the “Offering”).
BVT is pleased to announce the European Patent Office (EPO) has granted Patent Application No. 2693871 entitled: Apparatus for Treatment of Plants. With the grant by the EPO the Company can now validate the patent in the 38 countries that are Member States of the European Patent Organisation.
BVT announced that it has filed a patent application with the US patent office for a unique and novel system that allows the delivery of plant protection products to crops using
BVT announces its intention to undertake a non-brokered private placement (the “Offering”) to raise aggregate gross proceeds of up to C$1,500,000. The Offering will consist of up to 6,000,000 Units at a price of C$0.25 per Unit.
Today BVT announced that it has completed the preliminary technical screen process with the US Environmental Protection Agency (EPA) for registration of its bio-pesticide, BVT-CR7. The Company previously announced its submission for regulatory approval of BVT-CR7 on August 29, 2016.
BVT is pleased to announce it will be holding a web enabled conference call on Thursday January 19th at 2pm EST. CEO Ashish Malik will review milestones achieved to date, outline the opportunity ahead for the company, and provide details into 2017 company initiatives.
Connect with us
Have a question about BVT, the bee vectoring process, sustainable farming practices or just want to share feedback? We want to hear from you!